NL300007I2 - Preparaat voor de gereguleerde afgifte van een werkzame stof. - Google Patents
Preparaat voor de gereguleerde afgifte van een werkzame stof.Info
- Publication number
- NL300007I2 NL300007I2 NL300007C NL300007C NL300007I2 NL 300007 I2 NL300007 I2 NL 300007I2 NL 300007 C NL300007 C NL 300007C NL 300007 C NL300007 C NL 300007C NL 300007 I2 NL300007 I2 NL 300007I2
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- active substance
- controlled release
- release
- controlled
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicinal Preparation (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP84109832A EP0171457B1 (en) | 1984-08-17 | 1984-08-17 | Composition for the controlled discharge of an active ingredient, and its preparation |
| EP91202100A EP0467488B1 (en) | 1984-08-17 | 1984-08-17 | Composition for the controlled discharge of an active ingredient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL300007I1 NL300007I1 (nl) | 2000-08-01 |
| NL300007I2 true NL300007I2 (nl) | 2001-03-01 |
Family
ID=8192120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL300007C NL300007I2 (nl) | 1984-08-17 | 2000-05-22 | Preparaat voor de gereguleerde afgifte van een werkzame stof. |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP0171457B1 (nl) |
| CA (2) | CA1239034A (nl) |
| DE (3) | DE3485618D1 (nl) |
| NL (1) | NL300007I2 (nl) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1331338C (en) * | 1987-02-03 | 1994-08-09 | Dow Corning Corporation | Aqueous film-forming compositions for controlling the release of active agents and process of making same |
| US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
| GB8717168D0 (en) | 1987-07-21 | 1987-08-26 | Roussel Lab Ltd | Controlled-release device |
| IE60383B1 (en) * | 1988-05-27 | 1994-07-13 | Elan Corp Plc | Controlled release pharmaceutical formulation |
| US5055300A (en) * | 1988-06-17 | 1991-10-08 | Basic Bio Systems, Inc. | Time release protein |
| US5079005A (en) * | 1988-06-17 | 1992-01-07 | Gupta Kashmiri L | Time release protein |
| US5023080A (en) * | 1988-06-17 | 1991-06-11 | Basic Bio Systems, Inc. | Time release protein |
| US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane |
| US5178868A (en) * | 1988-10-26 | 1993-01-12 | Kabi Pharmacia Aktiebolaq | Dosage form |
| SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
| US5078888A (en) * | 1989-04-06 | 1992-01-07 | Dow Corning Corporation | Method for processing aqueous fermentation broths |
| US5024937A (en) * | 1989-04-06 | 1991-06-18 | Dow Corning Corporation | Method for processing aqueous fermentation broths |
| US5126146A (en) * | 1989-10-23 | 1992-06-30 | Merck & Co., Inc. | Cellulosic coating |
| ATE118345T1 (de) * | 1990-08-07 | 1995-03-15 | Pfizer | Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen. |
| GB9217295D0 (en) * | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| EP0670717B1 (en) * | 1992-11-30 | 1998-11-25 | Pfizer Inc. | Supported liquid membrane delivery devices |
| US5541231A (en) * | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US7098206B2 (en) | 1998-01-21 | 2006-08-29 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
| US6998400B2 (en) | 1998-01-22 | 2006-02-14 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
| AU2483599A (en) | 1998-01-29 | 1999-08-16 | Sepracor, Inc. | Pharmaceutical uses of optically pure (-)-bupropion |
| AU2349999A (en) | 1998-01-29 | 1999-08-16 | Sepracor, Inc. | Pharmacological uses of pure (+) -bupropion |
| US6033686A (en) * | 1998-10-30 | 2000-03-07 | Pharma Pass Llc | Controlled release tablet of bupropion hydrochloride |
| US6734213B2 (en) | 1999-01-20 | 2004-05-11 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
| US6855820B2 (en) | 1999-01-20 | 2005-02-15 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
| US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
| US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
| US6342496B1 (en) | 1999-03-01 | 2002-01-29 | Sepracor Inc. | Bupropion metabolites and methods of use |
| US6337328B1 (en) | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
| US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
| GB0025208D0 (en) | 2000-10-13 | 2000-11-29 | Euro Celtique Sa | Delayed release pharmaceutical formulations |
| US6932861B2 (en) | 2000-11-28 | 2005-08-23 | Fmc Corporation | Edible PGA coating composition |
| BR0115585A (pt) | 2000-11-28 | 2005-12-13 | Fmc Corp | Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento |
| WO2005016318A1 (en) | 2003-08-08 | 2005-02-24 | Biovail Laboratories Inc. | Modified-release tablet of bupropion hydrochloride |
| US8586085B2 (en) | 2004-11-08 | 2013-11-19 | Biokey, Inc. | Methods and formulations for making pharmaceutical compositions containing bupropion |
| KR100670798B1 (ko) | 2004-12-17 | 2007-01-17 | 한국전자통신연구원 | 데이터베이스 캐시 시스템 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2011587A (en) * | 1934-03-24 | 1935-08-20 | Kelp Ol Lab Inc | Coating for medical compound |
| US2602040A (en) * | 1949-06-28 | 1952-07-01 | Givaudan Corp | Enteric coated sympatholytic composition |
| US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
| SE324859B (nl) * | 1967-09-04 | 1970-06-15 | Ercopharm As | |
| US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
| DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
| US4016880A (en) * | 1976-03-04 | 1977-04-12 | Alza Corporation | Osmotically driven active agent dispenser |
| DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
| US4425363A (en) * | 1981-05-14 | 1984-01-10 | Burroughs Wellcome Co. | Treatment of tardive dyskinesia in mammals |
| US4428926A (en) * | 1981-12-18 | 1984-01-31 | Key Pharmaceuticals, Inc. | Sustained release propranolol system |
| JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
| IT1198386B (it) * | 1982-07-06 | 1988-12-21 | Lepetit Spa | Un prodotto a rilascio protratto contenente il suloctidile |
| IL70071A (en) * | 1982-11-01 | 1987-12-31 | Merrell Dow Pharma | Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient |
| GB8322007D0 (en) * | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
| US4740365A (en) * | 1984-04-09 | 1988-04-26 | Toyo Boseki Kabushiki Kaisha | Sustained-release preparation applicable to mucous membrane in oral cavity |
-
1984
- 1984-08-17 DE DE8484109832T patent/DE3485618D1/de not_active Expired - Fee Related
- 1984-08-17 CA CA000461272A patent/CA1239034A/en not_active Expired
- 1984-08-17 DE DE2000175031 patent/DE10075031I2/de active Active
- 1984-08-17 DE DE3486409T patent/DE3486409T2/de not_active Expired - Lifetime
- 1984-08-17 EP EP84109832A patent/EP0171457B1/en not_active Expired - Lifetime
- 1984-08-17 EP EP91202100A patent/EP0467488B1/en not_active Expired - Lifetime
-
1992
- 1992-07-10 CA CA616401A patent/CA1321754B/en not_active Expired - Lifetime
-
2000
- 2000-05-22 NL NL300007C patent/NL300007I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10075031I1 (de) | 2001-01-18 |
| EP0467488A2 (en) | 1992-01-22 |
| NL300007I1 (nl) | 2000-08-01 |
| EP0171457B1 (en) | 1992-03-25 |
| EP0171457A1 (en) | 1986-02-19 |
| EP0467488B1 (en) | 1995-10-11 |
| DE3486409D1 (de) | 1995-11-16 |
| DE3486409T2 (de) | 1996-04-25 |
| CA1321754B (en) | 1993-08-31 |
| CA1239034A (en) | 1988-07-12 |
| DE3485618D1 (de) | 1992-04-30 |
| DE10075031I2 (de) | 2004-07-01 |
| EP0467488A3 (en) | 1992-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300007I2 (nl) | Preparaat voor de gereguleerde afgifte van een werkzame stof. | |
| NL192914B (nl) | Werkwijze voor de bereiding van een antioxidant preparaat en daarmee verkregen preparaat. | |
| NL193218B (nl) | Werkwijze voor de bereiding van roestvrij staal. | |
| NL7710980A (nl) | Werkwijze voor het immunochemisch bepalen van fysiologisch werkzame materialen. | |
| NL194956B (nl) | Preparaat voor de afgifte van een heilzaam middel. | |
| NL187101C (nl) | Werkwijze voor de bereiding van een anthelmintisch werkzaam pour-on-preparaat. | |
| NL190746C (nl) | Hydrodynamisch afgewogen farmaceutisch preparaat met vertraagde vrijmaking van werkzame stof. | |
| NL7711358A (nl) | Werkwijze voor de bereiding van spiro-hydantoine- verbindingen. | |
| NL194042B (nl) | Werkwijze voor de bereiding van 3-fenyl-4-cyaanpyrrolen. | |
| NL187268B (nl) | Farmaceutische samenstelling tegen kanker en werkwijze voor de bereiding van de actieve stof. | |
| NL194747B (nl) | Preparaat voor de afgifte van diltiazem. | |
| NL191313C (nl) | Werkwijze voor de bereiding van p-chlooralkylbenzeen. | |
| NL7614633A (nl) | Werkwijze voor de bereiding van hydrofoob makende middelen. | |
| NL191628C (nl) | Droog poedervormig pleisterkalkmengsel en werkwijze voor de bereiding hiervan. | |
| NL179703C (nl) | Inrichting voor het continu gedurende lange tijd afgeven van een werkzame stof. | |
| NL181923C (nl) | Werkwijze voor de bereiding van beta-aminopropionamide. | |
| NL180664C (nl) | 1,8-alkyleen-3-carboxy-4-oxo-7-piperazinochinolinederivaten, werkwijze voor de bereiding daarvan en anti-microbiele preparaten die een dergelijke verbinding als werkzame stof bevatten. | |
| NL7701059A (nl) | Werkwijze voor de bereiding van insecticiden, ge- vormde insecticiden, alsmede werkwijze voor de bereiding van de werkzame verbindingen. | |
| NL183898C (nl) | Werkwijze voor de bereiding van cefamycine c. | |
| NL7904856A (nl) | Staal en werkwijze voor de bereiding van staal. | |
| ES517427A0 (es) | Procedimiento para la preparacion de trioxidos de triamina. | |
| ES519351A0 (es) | Procedimiento para la preparacion de benzotriazoles. | |
| NL7710612A (nl) | Werkwijze voor de bereiding van aldehyden. | |
| NL7807188A (nl) | Fluor bevattende oppervlak-actieve stof en werkwijzen voor de bereiding en toepassing ervan. | |
| NL193407B (nl) | Werkwijze voor de bereiding van 3-exomethyleencefamderivaten. |